{
    "dataset": {
        "title": "AI 응답 결과에 대한 품질 평가 데이터",
        "distributor": "한국지능정보사회진흥원",
        "year": "2023",
        "conversations": [
            {
                "conversation_id": 10062,
                "metadata": {
                    "topic": "기술과학",
                    "speakers": [
                        {
                            "id": 927,
                            "speaker_type": "human"
                        },
                        {
                            "id": 0,
                            "speaker_type": "bot"
                        }
                    ],
                    "evaluators": [
                        {
                            "evaluator_id": 927
                        },
                        {
                            "evaluator_id": 342
                        },
                        {
                            "evaluator_id": 1549
                        },
                        {
                            "evaluator_id": 1542
                        },
                        {
                            "evaluator_id": 2170
                        }
                    ],
                    "answer_evidence": [
                        {
                            "source": "https://www.sciencetimes.co.kr:443/news/%ec%a7%80%eb%82%9c%ed%95%b4-%ea%b5%ad%ec%82%b0-%ec%8b%a0%ec%95%bd-%ed%97%88%ea%b0%80-5%ea%b1%b4%eb%b3%b5%ec%a0%9c%ec%95%bd-41-%ea%b0%90%ec%86%8c/?cat=130"
                        }
                    ]
                },
                "utterances": [
                    {
                        "exchange_id": "c10062.e1",
                        "utterance_id": "c10062.u1",
                        "speaker_id": 927,
                        "utterance_text": "오늘 신약 개발에 대한 논문을 읽었는데 꽤 흥미롭더라, 지난해 국내에서 품목 허가를 받은 국산 신약이 몇 개정도 돼?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e1",
                        "utterance_id": "c10062.u2",
                        "speaker_id": 0,
                        "utterance_text": "지난해 국내에서 품목 허가를 받은 국산 신약은 5개로 역대 최다였습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e2",
                        "utterance_id": "c10062.u3",
                        "speaker_id": 927,
                        "utterance_text": "그럼 복제약 품목허가는 어떻게 진행되고있어?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e2",
                        "utterance_id": "c10062.u4",
                        "speaker_id": 0,
                        "utterance_text": "복제약 품목허가 건수는 전년보다 41% 감소했습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "no",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "no",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "no",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e3",
                        "utterance_id": "c10062.u5",
                        "speaker_id": 927,
                        "utterance_text": "지난해 의약품 허가·신고 현황은 어땠어?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e3",
                        "utterance_id": "c10062.u6",
                        "speaker_id": 0,
                        "utterance_text": "식약처는 지난해 신약 37개 품목을 허가했으며, 그중 국내 개발 신약이 5개 품목이었습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e4",
                        "utterance_id": "c10062.u7",
                        "speaker_id": 927,
                        "utterance_text": "그 5개 품목이 어떤건데?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e4",
                        "utterance_id": "c10062.u8",
                        "speaker_id": 0,
                        "utterance_text": "5개 품목은 비소세포폐암 치료제 '레이저티닙', 코로나19 항체치료제 '레그단비맙', 호중구감소증 치료제 '에플라페그라스팀', 급성 기관지염약 '백부근' 등 한약추출물, 역류성 식도질환약 '펙수프라잔'입니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "no",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "no",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "no",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e5",
                        "utterance_id": "c10062.u9",
                        "speaker_id": 927,
                        "utterance_text": "희귀의약품과 관련한 현황에 대해 설명해줘.",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e5",
                        "utterance_id": "c10062.u10",
                        "speaker_id": 0,
                        "utterance_text": "희귀의약품은 22개 품목을 허가해 전년 수준을 유지했습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e6",
                        "utterance_id": "c10062.u11",
                        "speaker_id": 927,
                        "utterance_text": "그럼 국내에서 허가된 코로나19 백신은 몇 개지?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e6",
                        "utterance_id": "c10062.u12",
                        "speaker_id": 0,
                        "utterance_text": "국내에서 허가된 코로나19 백신은 총 6개 품목입니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e7",
                        "utterance_id": "c10062.u13",
                        "speaker_id": 927,
                        "utterance_text": "어떤 게 있는지도 설명해줘.",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e7",
                        "utterance_id": "c10062.u14",
                        "speaker_id": 0,
                        "utterance_text": "국내에서 허가된 코로나19 백신 중 SK바이오사이언스가 제조한 아스트라제네카 백신과 삼성바이오로직스가 제조한 모더나 백신이 있습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e8",
                        "utterance_id": "c10062.u15",
                        "speaker_id": 927,
                        "utterance_text": "국내 기업 중 어떤 기업이 코로나19 항체치료제를 개발하고 허가받았어?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e8",
                        "utterance_id": "c10062.u16",
                        "speaker_id": 0,
                        "utterance_text": "국내 기업 셀트리온이 개발한 코로나19 항체치료제 '렉키로나주'가 처음으로 허가받았습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    },
                    {
                        "exchange_id": "c10062.e9",
                        "utterance_id": "c10062.u17",
                        "speaker_id": 927,
                        "utterance_text": "제네릭 의약품의 허가·신고 품목 수는 어떻게 변화하고 있지?",
                        "utterance_evaluation": []
                    },
                    {
                        "exchange_id": "c10062.e9",
                        "utterance_id": "c10062.u18",
                        "speaker_id": 0,
                        "utterance_text": "제네릭 의약품의 허가·신고 품목 수는 2020년에 비해 41% 감소했습니다.",
                        "utterance_evaluation": [
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            },
                            {
                                "linguistic_acceptability": "yes",
                                "consistency": "yes",
                                "interestingness": "yes",
                                "unbias": "yes",
                                "harmlessness": "yes",
                                "no_hallucination": "yes",
                                "understandability": "yes",
                                "sensibleness": "yes",
                                "specificity": "yes"
                            }
                        ]
                    }
                ],
                "conversation_summary": "두 사람은 신약 개발과 허가에 대해 이야기하고 있다. 국내에서 품목 허가를 받은 국산 신약은 5개로 역대 최다였고, 복제약 품목허가는 전년보다 41% 감소했다. 지난해 신약 37개 품목을 허가한 식약처는 국내 개발 신약이 5개 품목이었다. 희귀의약품은 22개 품목을 허가해 전년 수준을 유지했고, 국내에서 허가된 코로나19 백신은 총 6개 품목이다. 셀트리온이 개발한 코로나19 항체치료제 '렉키로나주'가 허가받았으며, 제네릭 의약품의 허가·신고 품목 수는 2020년에 비해 41% 감소했다.",
                "conversation_evaluation": {
                    "likeability": [
                        "yes",
                        "yes",
                        "yes"
                    ]
                }
            }
        ]
    }
}